SPHRY

Starpharma Holdings Ltd.

 
Sponsored ADR (1 ADS : 10 Ordinary) International Reporting
OTCQX International
 

OTC Disclosure & News Service

 

VivaGel BV granted QIDP and Fast Track designation by US FDA

Jan 11, 2017

OTC Disclosure & News Service

Abbotsford, VIC, Australia

This release includes additional documents. Select the link(s) below to view.

170112 - VivaGel BV QIDP and Fast Track Final.pdf

Copyright © 2017 OTC Markets. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.